Letter to the Editor re: "Expression of CD56 in patients with adenomyosis and its correlation with dysmenorrhea" from F. Wang and colleagues by Bhullar, J et al.
Accepted Manuscript
Title: Letter to the editor re: “Expression of CD56 in patients
with adenomyosis and its correlation with dysmenorrhea”
from F Wang and colleagues
Author: J. Bhullar J.A. Drury A.M. Kamal N. Tempest D.K.
Hapangama
PII: S0301-2115(16)30873-9
DOI: http://dx.doi.org/doi:10.1016/j.ejogrb.2016.08.025
Reference: EURO 9569
To appear in: EURO
Received date: 25-2-2016
Accepted date: 1-8-2016
Please cite this article as: Bhullar J, Drury JA, Kamal AM, Tempest N,
Hapangama D.K.Letter to the editor re: “Expression of CD56 in patients
with adenomyosis and its correlation with dysmenorrhea” from F Wang and
colleagues.European Journal of Obstetrics and Gynecology and Reproductive Biology
http://dx.doi.org/10.1016/j.ejogrb.2016.08.025
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Letter to the Editor – Brief Communication 
Letter to the editor re: “Expression of CD56 in patients with adenomyosis and its correlation 
with dysmenorrhea” from F Wang and colleagues 
Bhullar J1, Drury JA1, Kamal AM1,2, Tempest N1,3, Hapangama DK1,3 
1Department of Women's and Children's Health, Institute of Translational Medicine, 
University of Liverpool, Liverpool, L8 7SS, UK. 
2The National Center for Early Detection of Cancer, Oncology Teaching Hospital, Baghdad 
Medical City, Baghdad, Iraq. 
3Liverpool Women’s Hospital NHS Foundation Trust, Liverpool, L8 7SS, UK. 
 Dear Editor,  
We read with interest the article by Wang et al.(1) on the role of CD56 in adenomyosis. The 
authors, using a mouse monoclonal antibody and immunohistochemistry, reported that 
there was increased expression of CD56 in ectopic adenomyotic tissue in patients suffering 
dysmenorrhoea when compared to the eutopic tissue and corresponding ectopic 
adenomyotic tissue from patients without dysmenorrhoea.  
The mouse monoclonal antibody (MOC31, AbCam #ab187270, Cambridge Science Park, 
Cambridge, UK) that the authors employed in their work is raised against human epithelial 
cell adhesion molecule (EpCAM) protein that is known to be expressed by endometrial 
epithelial cells according to the AbCam website.  The expression pattern of EpCAM in the 
human endometrium is available in the Human Protein Atlas 
(http://www.proteinatlas.org/ENSG00000119888-EPCAM/tissue/endometrium) and is 
similar to the figures presented in Wang et al’s manuscript. It is commonly used to isolate 
endometrial epithelial cells in endometrial studies (2). 
CD56, also known as Neural Cell Adhesion Molecule (NCAM), is a well-established marker 
for uterine Natural Killer (uNK) cells. There is a plethora of papers which describe the 
immuno-expression pattern of CD56 in the endometrium, and there are validated scoring 
methods of CD56 expressing uNK cells in the endometrium (3).  Figure 1 illustrates CD56 
immuno-staining using Novocastra clone 1B6 (Leica Biosystems, Newcastle, UK) in cells 
within the human eutopic endometrium, and matched ectopic endometriotic lesions and 
adenomyosis from our group.  In accordance with previously published work and the data 
available on the Human Protein Atlas (http://www.proteinatlas.org/ENSG00000149294-
NCAM1/tissue/endometrium) uNK cells were localised within the stroma, while the 
glandular epithelium remained immuno-negative. We were surprised that there was no 
mention of uNK cells and the numerous previous publications on endometrial CD56 
expression (reviewed in(4)) in the current manuscript. In particular, the absence of 
reference to previous papers on adenomyosis, for example the 1998 manuscript by a well-
known uNK cell research group in the UK was a striking omission (5).   
When consulting the Abcam website monoclonal anti-human CD56 antibody clone MOC1 
(AbCam, #ab133345) was one of several available antibodies. It seems that the authors 
could have confused MOC1 with MOC31. 
Considering the information presented by the authors on the antibody they used; the 
known, previously published and well-established expression pattern of EpCAM and CD56 in 
the human endometrium; and the use of IHC only as a method to confirm the protein of 
interest by the authors in this manuscript, we conclude that Wang et al.(1) may have 
misinterpreted the EpCAM protein immuno-localisation for CD56 in their paper. In order to 
prevent misdirection of scientific readership, we believe that this paper needs to be revised 
accordingly to confirm whether the conclusions reached by the authors can be supported by 
the presented data. 
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 Figure legend 
Figure 1 Representative micrographs showing CD56 (Novocastra clone 1B6, Leica 
Biosystems, Newcastle, UK) immunohistochemical staining of human secretory phase 
eutopic endometrium, endometriosis and adenomyosis lesions. Brown DAB staining shows 
localisation of CD56 positive uterine Natural Killer cells with blue nuclear haematoxylin 
counterstain. In all micrographs, CD56 immunostaining is localised to the stromal 
compartment, while the glandular epithelium remains negative. A; secretory phase eutopic 
endometrium from a patient with endometriosis. B; Matched peritoneal ectopic 
endometriotic lesion. C; secretory phase eutopic endometrium from a patient with 
adenomyosis. D; matched adenomyotic lesion. Magnification x400. 
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